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PEMBANGUNAN HIDROKSIAPATIT YANG DIPERKUATKAN DENGAN 
TIUB-NANO KARBON  
 
ABSTRAK 
 
Persamaan komposisi kimia hidroksiapatit (HA) dengan fasa mineral tulang 
dan keserasian biologinya yang sangat baik memenuhi keperluan bahan reka bentuk 
untuk pembesaran dan pembaikan tulang. Walaubagaimanapun, aplikasi HA dalam 
peranti menanggung beban adalah terhad disebabkan ciri mekanikal yang lemah. 
Tiub-nano karbon (CNTs), dengan ciri kekukuhan dan kekuatannya yang baik, 
mempunyai potensi besar dalam bidang kejuruteraan tisu. Kekukuhan dan kekuatan 
CNTs, digabungkan dengan saiz yang kecil dan kawasan permukaan antara muka 
yang besar, mencadangkan CNTs mempunyai potensi yang amat besar untuk 
dijadikan ejen pengukuhan HA. Dalam kajian ini, komposit HA/MWCNTs/BSA 
dengan ciri-ciri mekanik ditambah baik untuk digunakan sebagai bahan pengganti 
tulang telah dibangunkan. Serbuk komposit HA/MWCNTs/BSA dengan pelbagai 
jenis MWCNTs (MWCNTs-OH, MWCNTs-COOH, MWCNTs) telah berjaya 
disediakan. Keputusan yang diperolehi menunjukkan bahawa komposit HA yang 
disediakan dengan menggunakan MWCNTs-COOH dan BSA dengan daya 
mampatan 29.75 MPa menunjukkan keputusan terbaik berbanding dengan komposit 
HA yang disediakan dengan menggunakan MWCNTs yang lain. Komposit 
HA/MWCNTs-COOH/BSA tersebut  direndam dalam SBF selama 7 , 14, 21 dan 28 
hari pada suhu 37 °C sebagai ujian LQYLWUR biologi bertujuan untuk menyiasat kesan 
SBF terhadap ciri-ciri mekanikal komposit. Daya mampatan komposit telah menurun 
dari  29.57 kepada 9.11 MPa selepas 28 hari direndam dalam SBF. Nano-HA dengan 
saiz zarah antara 20 ke 25 nm telah berjaya dihasilkan dengan menggunakan kaedah 
 xviii 
   
pemendakan larutan Ca(NO3)2.4H2O dan (NH4)2HPO4. Komposit Nano-
HA/MWCNTs-COOH telah berjaya dihasilkan menggunakan kaedah pemendakan. 
Komposit tersebut dikalsin pada suhu 600, 800 dan 1000 °C. Kekuatan mampatan 
komposit Nano-HA/MWCNTs-COOH selepas pengkalsinan  pada suhu 600, 800 dan 
1000 °C adalah masing-masing 27.01 , 27.78 dan 37.43 MPa. Kesan sitotoksik 
sampel ujian dengan kepekatan yang berbeza telah dinilai dengan assay MTT 
terhadap fibroblast kolon manusia normal. Pada kepekatan yang rendah, semua 
komposit didapati tidak sitotoksik apabila dirawat kepada sel-sel fibroblast manusia 
dan tidak menyebabkan kesan sitotoksik pada percambahan sel, manakala apabila 
kepekatan sampel ditingkatkan, pengurangan daya maju sel dapat diperhatikan. 
Komposit HA/MWCNTs-OH/BSA, HA/MWCNTs-COOH/BSA, dan 
HA/MWCNTs/BSA menunjukkan kesan-kesan  percambahan pada sel-sel. Sampel 
yang digunakan dalam kajian ini tidak menunjukkan kesan toksik apabila 
percambahan telah didorong. Tambahan pula, Nano-HA/MWCNTs-COOH/BSA 
membayangkan kesan percambahan pada rangkaian sel CCD-18Co. Komposit 
HA/MWCNTs-OH/BSA, HA/MWCNTs-COOH/BSA, HA/MWCNTs/BSA dan 
Nano-HA/MWCNTs-COOH/BSA adalah antara pilihan yang baik untuk 
membangunkan bahan-bahan ortopedik kerana komposit-komposit ini lulus 
keseluruhan tapisan, dan kesan yang diingini telah ditunjukkan di dalam badan. 
Tambahan pula, komposit-komposit ini boleh memasuki pasaran industri dengan 
kadar kejayaan yang agak tinggi. 
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DEVELOPMENT OF MULTIWALLED CARBON NANOTUBES 
REINFORCED HYDROXYAPATITE  
ABSTRACT 
 
The similarity of the chemical composition of hydroxyapatite (HA) to the 
mineral phase of bone and their excellent biocompatibility meets the requirement of 
materials designed for bone repair and augmentation purposes. However, the 
application of HA in load bearing devices is limited by its poor mechanical 
properties. Carbon nanotubes (CNTs), with their outstanding stiffness and strength, 
have good potential applications in tissue engineering. Their strength and stiffness, 
combined with their small size and large interfacial surface area, suggest that they 
may have great potential as a reinforcing agent for HA. In this study, 
Hydroxyapatite/Multiwalled carbon nanotubes/Bovine serum albomin 
(HA/MWCNTs/BSA) composites with highly improved mechanical properties for 
use as bone replacement materials were developed. The HA/MWCNTs/BSA 
composites powders with different types of MWCNTs (MWCNTs-OH, MWCNTs-
COOH, MWCNTs) were successfully prepared. The results show that the HA 
composites which are prepared by using MWCNTs-COOH and BSA with 
compressive strength of 29.75 MPa has the highest results in comparison with HA 
composites which are prepared by using other types of MWCNTs. The 
HA/MWCNTs-COOH/BSA composite immersed in SBF for 7, 14, 21 and 28 days in 
37 °C as in vitro biological test in with the purpose to investigate the SBF effects on 
mechanical properties. The compressive strength of immersed composites in SBF 
was decreased from 29.57 to 9.11 MPa after 28 days immersing. The nano-HA with 
particle size in the range 20 to 25 nm was successfully synthesized using 
precipitation technique from Ca(NO3)2.4H2O and (NH4)2HPO4 solution. The Nano-
 xx 
   
HA/MWCNTs-COOH/BSA composites were successfully produced using 
precipitation technique. The synthesized composites calcined at different 
temperatures of 600, 800 and 1000 °C. The compressive strength of Nano-
HA/MWCNTs-COOH/BSA composites after calcination at 600, 800 and 1000 °C 
are 27.01, 27.78 and 37.43 MPa respectively. The cytotoxic effect of the test samples 
with different concentrations was evaluated by MTT assay against normal human 
colon fibroblast. At low concentration, all developed composites  were found to be 
non-cytotoxic when treated to the human fibroblast cells and did not elicit cytotoxic 
effects on cell proliferation, whereas when the concentration of samples was 
increased, the reduction in cell viability was observed. The HA/MWCNTs-OH/BSA, 
HA/MWCNTs-COOH/BSA, and HA/MWCNTs/BSA composites showed the 
proliferative effects on the cells. The samples used in the present study did not show 
toxic effects as proliferation was induced. Furthermore, the Nano-HA/MWCNTs-
COOH/BSA implies a cell proliferative effect on CCD-18Co cell line. 
HA/MWCNTs-OH/BSA, HA/MWCNTs-COOH/BSA, HA/MWCNTs/BSA and 
Nano-HA/MWCNTs-COOH/BSA composites are possibly a good choice to develop 
orthopedic materials because these materials passed the entire filter, in which a 
desirable effect was elicited in the body. Furthermore, these compounds can enter the 
market industry with a possibly high success rate. 
 
 1 
   
1 CHAPTER ONE  
INTRODUCTION 
 
Nowadays medical world is changing from treating injured organs of bodies by 
long surgical operations to changing the damaged organ with synthesised implants. 
Hard tissue and bone substitute materials are mostly synthesised using bioactive and 
tough materials, which have chemical and structure similarity to the hard tissues. 
Study of biomaterials includes the use of them in a new composite material with 
improved properties, modification of the microstructure of the present biomaterials 
and chemical synthesis of new biomaterials. Material scientists are currently working 
on projects for the synthesis of biocompatible materials, which mimic the properties 
of natural bone (Vallet-Regí et al., 2004). 
 
Biomaterials are class of engineering materials, which can be used in animal 
body, tissue replacement, reconstruction, and regeneration without any long-term 
adverse effects. Among the different classes of biomaterials, bioceramics is one of 
the important classes of available material used as human-body implants (Dorozhkin, 
2010).  
 
1.1 Bone 
Bone is a natural composite material that contains 10 wt.% water, 20 wt.% 
organic materials, and 70 wt.% minerals (Shi et al., 2006). The organic components 
mostly comprise collagen fibrils and some cement-like substances, whereas the 
inorganic mineral materials of bone are composed of calcium-deficient carbonate 
substituted apatite comprising calcium (Ca2+) and phosphate (PO4
3-) ions, which have 
similar structures to that of hydroxyapatite (HA, Ca10(PO4)6(OH)2) (Legeros et al., 
 2 
   
1993). According to its porosity, bone structure is classified into two categories: 
compact (or cortical) bone and trabecular (or cancellous) bone. Porosity, density, and 
molecular structure of bone affect its strength and mechanical properties (Rho et al., 
1998). 
 
1.2 Bone substitute materials 
Ideal bone replacement materials should be biocompatible, nontoxic, 
osteoinductive and osteoconductive, stable, capable of long-term integration of 
implant, and possess excellent mechanical properties (Horch et al., 2006; Kao and 
Scott, 2007). Materials for body repair have been designed and used clinically since 
1960s. Many different kinds of synthetic replacements materials have been 
developed in the last decades as bone replacement materials. Synthetic materials 
include ceramic-based materials such as calcium phosphate, calcium sulphate, 
bioglass, polymers, ceramics and composites (Tadic and Epple, 2004; Tadic et al., 
2004; Horch et al., 2006; McAllister and Haghighat, 2007; Asti et al., 2008). 
Composites are combinations of various materials, such as bioactive calcium 
phosphates and polymers, which can be used as bone replacement materials with 
improved mechanical properties (Boccaccini and Blaker, 2005, Chesnutt et al., 2009, 
Xu et al., 2009).  
 
1.3 Hydroxyapatite (HA) and Hydroxyapatite based composite 
The composition of HA is similar to the mineral phase of natural bone. HA is 
an great material for bone replacement, and has been used in clinical applications 
such as dental and orthopedic applications in bulk form and as filler and coating for 
more than three decades (Suchanek et al., 1998). However, the poor mechanical 
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properties of HA have prevented it from being used in major load-bearing devices. 
The compressive strength of dense HA is four times greater than that of compact 
bone, but it still has low tensile strength and fracture toughness. 
 
The recent researches in biomaterials is focused on improving the weak points 
of calcium phosphates and hydroxyapatite ceramics including their low 
bioresorbability, surface area, bioreactivity, and the biological properties by 
exploring  the special advantages of nanotechnology (Bohner et al., 2012). 
Nanotechnology has potential to synthesize the inorganic crystals with nano particle 
size, characterized by a high bioresorbability and surface area, which increase the 
bioreactivity of crystals. The trend is shifting toward nanotechnology to improve the 
biological responses of HA, because nano-HA is a constituent of bone (Roveri et al., 
2010). 
 
Nano-HA particles are similar to bone crystals, therefore using nano-HA is 
considered to be very promising for use in in orthopedic application. 
Nanotechnology offers an exclusive approach to overcome the weaknesses of several 
conventional materials. Nanotechnology is include the almost all disciplines of 
human life such as nanomedicine and nanofabrics. Compare to materials with micro 
size particles, the nano-sized materials are suggest more improved performance, 
because these materials have higher ratio of surface area to volume and unusual 
chemical/electronic synergistic effects (Roveri et al., 2010). 
 
Zhou et al. (2011) studied the important role of size and crystal morphology 
control of nano HA particles for bone tissue engineering. Their review revealed that 
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developing the HA biomedical materials will benefit from nanotechnology 
progresses.  
 
Several methods have been used to synthesize HA. The HA was produced 
through a hydrothermal process by exposing fluorapatite (Ca10(PO4)6F) to high 
pressures and temperatures by Levitt at 1996s. Several methods, such as 
hydrothermal exchange of coral, solid-state reaction between tricalcium phosphate 
(TCP) and tetracalcium phosphate (TTCP) or between TCP and CaO, as well as wet 
chemical methods including aqueous precipitation, hydrolysis, and sol–gel 
techniques, have been used (Akao et al., 1981; Legeros 1993; Weng et al., 1998; Liu, 
2001; Bezzi et al., 2003; Vijayalakshmi et al., 2006). Among the different methods 
of HA synthesis, precipitation method is the most prevalent. It is a simple method 
because of its ease of operation, tailoring composition, and scaling up for mass 
production. Precipitation method is a wet chemical reaction between calcium 
precursors (such as calcium nitrate (Ca(NO3)2), calcium carbonate (CaCO3), and 
calcium hydroxide (Ca(OH)2) and phosphate precursors (such as diammonium 
hydrogen phosphate ((NH4)2HPO4) and orthophosphoric acid (H3PO4)) under 
controlled temperature and pH (Kweh et al., 1999; Munguía et al., 2005; Rhee, 2002; 
Santos et al., 2004).  
 
The properties of HA (including physical, physicochemical, mechanical, and 
biological properties, as well as heat treatment behavior) and its preparation process 
are well understood. After decades of research, poor mechanical properties of HA are 
reportedly its main disadvantage (Hench, 1998; Kweh et al., 1999; Orlovskii et al., 
2002). Carbon nanotubes (CNTs) have outstanding mechanical properties and 
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chemical stability because of their cylindrical graphitic structure. Carbon is one of 
the known basic foundations in the development of life on earth (Cheng et al., 2009). 
Since the investigation of CNTs by Iijima in 1991, increasing research has focused 
on the use of CNTs for reinforcement (Iijima in 1991; Gojny et al., 2003). Their 
strength and stiffness, combined with their small size and large interfacial area, 
suggest that they may have great potential as reinforcing agents for HA. 
 
The mechanical properties of CNTs in composites is complicated. The strength 
and stiffness of CNTs can be transferred to the matrix depending on the amount of 
interfacial bonding between the two phases. Response of multi-walled CNTs 
(MWCNTs) to human lung epithelial cells, osteoblast-like cells, and primary 
osteoblast cells showed that these cells attached and survived on MWCNTs, although 
minimal proliferation effect is observed. The dimensions and spacing of CNTs may 
have important role to determining consequent cell spreading and cell proliferation 
(Giannona et al., 2007). 
 
HA–CNT composites, combining HA and CNTs, can improve mechanical 
properties of HA for use in a wider range of biomedical applications. The first known 
publication on HA–MWCNTs composites were introduced in 2004 (Zhao et al, 
2004). They combined sodium dodecyl sulphate (SDS)-treated MWCNTs and nitric 
acid-treated MWCNTs in a solution with Ca(NO3)2, followed by the addition of 
(NH4)2HPO4 to form HA. The resulting precipitate was dried and hot pressed at 1200 
°C for 20 h. Compressive strengths improved from 63 MPa for pure HA to 87 MPa 
for SDS-functionalized MWCNTs and 102 MPa for nitric acid-functionalized 
MWCNTs. Xu et al. (2009) reported on the mechanical properties and response of 
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osteoblast-like cells to HA–MWCNTs composites densified by spark plasma 
sintering. HA powder and MWCNTs were dry mixed and then consolidated using 
spark-plasma sintering at temperatures ranging from 900 °C to 1200 °C. Hardness 
and Young’s modulus were evaluated, and osteoblast-like cells were cultured for two 
and four days. The mechanical properties reportedly increased in hardness and 
Young’s modulus compared with HA. They also reported an increase in cellular 
response to the composites compared with HA alone (Xu et al., 2009).  
  
Kealley et al. (2006; 2008) reported the only decrease in mechanical properties 
with the addition of MWCNTs in the literature. They added 2 wt.% MWCNTs with 
graphite impurities in situ while precipitating HA. The material was then calcined 
and isostatically hot pressed with 100 MPa at 900 °C in argon. Results showed that 
the hardness decreased compared with pure HA, whereas the toughness remained the 
same. The authors attributed the decrease in mechanical properties to the presence of 
graphite clumps. Another work involving hot pressing was conducted by Meng et al. 
(2008). HA was made by precipitation method and then calcined at 900 °C. Thin, 
short MWCNTs were treated with acid and then mixed with HA powder. The authors 
confirmed that HA remained phase pure during heat treatment, and found 28% 
improvement in flexural strength and 50% toughness, as evaluated by indentation 
fracture, both at a loading of 7 vol.%. At loadings higher than this value, mechanical 
properties decreased (Meng et al., 2008). 
 
Bovine serum albumin (BSA), a protein with similar size of growth factors, 
was used as a model protein. The BSA release profile and its release efficiency at 
different BSA adding times were investigated systemically (Yu and Wei, 2011). 
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Generally, BSA is used as a matrix or soft template to induce calcium carbonate 
formation (Yao et al., 2009). The improvement in mechanical properties with the 
addition of BSA can be explained by the fact that proper amounts of BSA can 
promote CPC crystal growth (Burke et al., 2000; Hovarth et al., 2000; Sadollah et al., 
2012). 
 
The addition of BSA can increase the compressive strength of calcium 
phosphate composites (Chew et al., 2011; Low et al. 2011). The results demonstrated 
that the addition of BSA and MWCNTs to the CPC caused an increment in the 
compressive strength of the CPC composite from 1 MPa for pure CPC to more than 
14 MPa for CPC/MWCNTs/BSA composite. This further improvement in the 
mechanical properties might be due to the capability of BSA to promoting CPC 
crystal growth (Boccaccini et al., 2007). 
 
1.4 Problem statement 
With the aging population, the requirement for biomaterials has increased 
significantly, and more attention has been drawn to hard tissue research. The 
significant attention on new and biocompatible bone graft materials is ascribed to 
decades of bone graft usage to repair osseous defects causing from traumas and 
diseases. More than 800,000 grafting procedures are performed annually (Tusli, 
2004).  
 
The development and improvement of synthetic materials for in vivo biological 
applications is highly desirable as an alternative to allografts and autografts. 
Hydroxyapatite (HA) has been extensively studied as a hard tissue and bone graft 
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biomaterial due to its crystallographic and biologically active characteristics 
stemming from its chemical similarity to the mineral similarity to carbonated apatite 
in teeth and bones. Synthetic HA is a biologically active calcium phosphate 
bioceramic that is generally used for coating the orthopedic metal or utilized as bone 
substitute material (Lange and Donath, 1989; Sadollah et al., 2012). While HA has 
the ability to promote bone growth along its surface, its mechanical properties, 
particularly its strength and toughness, are insufficient for major load-bearing 
applications. Reinforcing HA with a second phase offers a possibility to overcome 
these limitations.   
 
An ideal reinforcing material would provide mechanical integrity to the 
composite without negatively impacting its biological properties. Carbon nanotubes 
(CNTs), considered one of the strongest and stiffest materials available, have 
excellent potential to accomplish this.. Furthermore, the surface of the CNTs can be 
functionalised to improve that interaction.   
 
Already, CNTs have shown potential for reinforcing polymers, and to some 
degree metals and ceramics, as well. Several publications have addressed HA-CNT 
composites, specifically, but studies thus far have lacked a cohesive view of all 
aspects of the composites, which encompass production, processing, densification 
techniques, mechanical behaviour, and biological behaviour. Special attention must 
be given to the biological impact of the CNTs presence, as current research is 
conflicting as to whether CNTs might induce a cytotoxic response or perhaps even 
improve cellular processes (Kealley et al., 2006; White et el., 2007). Regarding the 
use of CNTs in bone replacement material, another concern is cytotoxicity. There are 
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several researches that focus on the harmful impact of carbon nanotubes on cell 
proliferation and adhesive ability. CNTs have excellent mechanical properties and 
some researches indicated that they are biocompatible materials in human body. 
(MacDonald et al, 2005; Price et al., 2003; Hu et al., 2004).  
 
Nanoscale hydroxyapatite (nano-HA) is the main component of mineral phase 
of natural bone. Nano HA powders have greater surface area, thus it can exhibit the 
improvement in sinterability and enhanced better densification and as a consequence, 
improve mechanical properties (Legeros, 1993). Nano-HA is supposed to have better 
bioactivity and biocompatibility and due to its small size and huge specific surface 
area, they may have exclusive properties. Study by Webster et al. (2000) have 
revealed that in comparison with micron sized ceramic materials,  nano sized 
materials demonstrated a significant increment in protein adsorption and osteoblast 
adhesion. A large surface area is necessary for cell attachment and growth. The large 
pore volume is also required to accommodate and subsequently deliver a cell mass 
sufficient for tissue repair. The highly porous biomaterials also desirable for the easy 
deffusion of nutrients to and waste products from the implant and for vascularization, 
which are important requirements for the regeneration. This research is aimed at 
synthesis of HA/MWCNTs/BSA, with improved mechanical properties using 
MWCNTs as reinforcing material.  
 
1.5 Research objectives 
The aims of the research is to develop biocompatible composites with highly 
improved mechanical properties for use as bone replacement materials. The 
objectives will be achieved through the outlined steps as follows:  
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i. To investigate the mechanical strength of HA/MWCNTs composites with 
different types of MWCNTs and BSA. 
ii. To synthesis nano-HA/MWCNTs and study the mechanical strength of nano-
HA/MWCNTs/BSA composite for use as bone replacement materials. 
iii. To investigate the cytotoxicity effect of developed composites via in vitro cell 
culture. 
 
1.6 Scope of study 
This study covers the development of hydroxyapatite composites, 
characterization of composites and cytotoxicity study. Calcium phosphate-based 
biomaterials have revealed great performance without side effects on the in vitro or 
in vivo. However, the final composites have relatively low compressive strength, 
which limits their applicability in orthopedics. The MWCNTs have been chosen 
because of their impressive properties, such as mechanical strength, stiffness and it is 
suitable to apply in biological and biomedical systems. Furthermore, BSA has been 
chosen because it can act as a promoter of HA crystal growth when bonded to a 
surface. Thus, the addition of MWCNTs and BSA could lead to the improvement of 
mechanical properties by modifying the properties of crystallites. The interfacial 
bonding between HA, MWCNTs, and BSA is an important consideration for 
composite materials.  
 
HA has the ability to promote bone growth along its surface, but its mechanical 
properties, especially compressive strength, is not sufficient for load-bearing 
applications. Nanoscale HA with ultrafine structure and large surface area has been 
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synthesised for the next step of this research because it has a higher level of 
biocompatibility compared with conventional HA.  
 
In this study, the biological effects of the developed composites on fibroblast 
cells are studied and the experimental results are compared with the predicted results 
of ANN technique. The kinetics of nano-HA precipitation from aqueous solution at 
the condition of high pH value in range between 10.5 to 11 investigated with purpose 
of synthesis appropriate nano-HA for use as bone replacement materials. 
Furthermore, the effect of different temperature on rate of conversion were studied. 
Synthesized composites are characterized through surface area analysis, scanning 
electron microscopy (SEM), surface and pore size measurements (Brunauer–
Emmett–Teller, BET), transmission electron microscopy (TEM), X-ray 
diffractometer (XRD) and Fourier transform infrared spectroscopy (FTIR). 
 
1.7 Organization of the thesis 
This thesis is included five major chapters. Each chapter represents an integral 
part of the main work and is sequentially arranged. The thesis is organized as 
follows. 
 
Chapter one provides an overview of the overall research project. The problem 
statement is written after reviewing different types of bone replacement materials. 
The research objectives, scope of study, and organization of the thesis are provided 
in this chapter. 
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Chapter two presents a detailed review of literature on the properties, 
characteristics, and production of calcium phosphate-based composites. It also 
reviews relevant studies on MWCNTs, BSA, and the current status of MWCNTs as 
reinforcement materials. The chapter also reviews an ANN method that can be used 
as a potent tool to predict the cytotoxic properties of composites. Finally, a literature 
review on the kinetic study of the precipitation reaction of HA synthesis is presented. 
 
Chapter three focuses on the materials used and the experimental processes 
which employed to synthesis of composites. This chapter also presents in detail the 
experimental methodologies used in the synthesis of different composites and the 
synthesis of nanoscale HA. It briefly describes the characterization of the 
composites.  
 
Chapter four presents and discusses the results obtained in this work. The first 
section of this chapter contains results and discussion of the production of calcium 
phosphate based composite, in vitro study of composites, and characterization of the 
synthesized composite. The succeeding part includes the formation of 
HA/MWCNTs/BSA using conventional HA and different types of MWCNTs, 
followed by characterization of the composites. The third part of this chapter 
contains a discussion of nano-HA synthesis through precipitation reaction and 
preparation of HA/MWCNTs/BSA composite using nano-HA, followed by 
characterization of composites. In last part, the cytotoxicity of the composites was 
assessed with human fibroblasts cells (CCD-18 Co), which were inoculated and 
exposed to different concentrations of different types of sample powder. 
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Chapter five presents a summary of the results of this research and offers 
recommendations for future studies related to this research work. 
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2 CHAPTER ‎TWO 
LITERATURE REVIEW 
 
The purpose of this chapter is to give a background relating to bone 
replacement materials (particularly CPC and HA composites) and CNTs. Detailed 
information relating to processing techniques and characterization; Heat treatment; 
mechanical properties and biological responses of the composite materials; kinetic 
study and mathematical analysis will be included in chapter 3 and 4. This literature 
give an overview of the bone nature and different types of materials currently use or 
under development that can replace bone and assist to repair it. The background on 
CNTs, which chosen as reinforcing material for CPC and HA is also elaborated. 
Furthermore, mechanical properties and cytotoxicity of composites are discussed.  
 
2.1 Bone 
Bone is an organ with critical functions in human physiology. Some of these 
functions include protection, movement and support of other organs, blood 
production, mineral storage and homeostasis, and blood pH regulation (Porter et al., 
2009). Bone is a complex natural organic–inorganic ceramic that consists of collagen 
fibrils embedded with well-arrayed nano crystalline rod shaped inorganic material 25 
nm to 50 nm in length (Poinern et al., 2009; Zhou and Lee, 2011). Bone stores 99% 
of the total body calcium, whereas the remaining 1% circulates in the blood (Rho et 
al., 1998). 
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2.1.1 Bone Structure 
Figure 2.1 shows that the structural order in bone occurs at different 
hierarchical levels and reflects the materials and mechanical properties of its 
components. It also shows that the microstructure of compact bone comprises of 
osteons with haversian canals and lamellae; at the nanoscale, the structural units are 
collagen fibers comprised of bundles of mineralized collagen fibrils (Zhou and Lee, 
2011). Hydroxyapatite (HA) with a general formula of Ca10(OH)2(PO4)6 is the main 
inorganic material component of bone (Habraken et al., 2007; Hutmacher et al., 
2007). 
 
Figure 2.1: The hierarchical structure of bone (Zhou and Lee, 2011) 
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Despite the diversity of external forms of bone, its internal structure is 
relatively consistent. Bone structure is hierarchically organized (Weiner and Wagner, 
1998; Hellmich and Ulm, 2002). Skeleton comprised from two hundred six bones 
with different size, shape and weight. This complex internal and external structure is 
responsible for 9 kg of adult human weight. Bones are rigid, living tissue, constantly 
tearing down and rebuilding them, without this repair and reinforcement of even 
minor weak spots, we would break bones on a regular basis. Bone serves multiple 
functions, including mechanical, synthetic, and metabolic.  Through mechanical 
function, bone provides the frame work for the body; also provide protection for 
internal soft tissue like brain, heart, liver and muscle. Bone and several associated 
elements cartilage, connective tissue, vascular elements, and nervous components act 
as fundamental organ generating movement force for the body (Gilbert, 2001).  
 
Bone is multifunctional tissue and not only having protective function. The 
spongy tissue inside interior cavity of long bones and interstices of cancellous bone 
produces immature cells, called stem cells, which later develop to red blood cell. 
Bone marrow produces other elements of the blood such as white blood cells and 
platelets (Haywood, 2008). 
 
In addition to mechanical function, bone serve metabolic role by reserving 
minerals, fats, and acid-base balance. The bone stores 99% of the body's calcium and 
85% of the phosphorus. The yellow bone marrow of long bones acts as storage of 
fats. Bone balances acid, and base in blood, when acid production is increased, renal 
net acid excretion, and kidney function is not enough to buffer the condition, bone  
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release of  Ca2+ into the urine, balances the condition (Frost and Saunders-Smith, 
2001; Lemann et al., 2003).  
 
Bone structure is not uniformly solid material; it consists of both living tissue 
and non-living substances. Generally, bone is categorized into two types: Cortical 
bone, also known as compact or dense bone and Trabecular bone, also known as 
cancellous or spongy bone, this classification is done base on porosity and the unit 
microstructure. Cortical tissue give bone smooth, white, and solid appearance, its 
porosity is 5-30%. Compact bone is account for 80% of the total bone mass of an 
adult skeleton. Twenty percent of remaining of total bone mass is called trabecular 
(cancellous or spongy). It is the porous or cellular structure, which fills the interior of 
short bones and flat bones as well as in the inner part of bony tuberosities under 
muscle attachments. Its porosity reaches to 30–90% (Wolstenholme et al., 1956; 
Currey, 2002; Symposium, 2009).  
 
Bone cell classified to three groups of cell osteoclast, osteocblast, and 
osteocytes. Osteoclast cell are bone marrow originated cell line, they are leucocytes 
related cell line. Osteocblast, is the differentiated osteogenic cells and is responsible 
for the synthesis and mineralization of new bone therefore they called as bone-
forming cells (Green, 1994). Osteocytes are the inner cell and the most abundant cell 
type in the bone, comprising more than 90% of all cells within the bone matrix or on 
bone surfaces the inner cell of the bone. They derived from osteoblasts during the 
formation of new bone. Osteocytes create network between bone cells, endothelial 
cells, and hematopoietic cells (Link, 2013). Osteoclast dissolute mineralized matrix 
of bone, and release the minerals, this process called bone resorption breaking up the 
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organic bone, and end in release calcium in blood (Figure 2.2) (Green, 1994; 
Symposium, 2009). 
 
Bone at the lowest level made of remarkably complex arrangements of fibrous 
protein, collagen (organic composition), strengthened with hydroxyapatite crystals 
(inorganic composition), there some other material like water, unknown protein, 
polysaccharide. Water is very important as it determined the mechanical behavior 
and provide medium for organic and inorganic compound which together make bone 
matrix (Field et al., 1974; Legros et al., 1987). 
 
At the macrostructural level of hierarchical organization (observation scale of 
several millimeters to centimeters), bone structure is classified into cortical (or 
compact) bone and trabecular (or cancellous) bone according to its porosity. Cortical 
bone porosity is in the range of 5% to 10% and usually found along the exterior shaft 
section of long bones. Cortical bone forms the outer shell around the trabecular bone 
in joints and in vertebrae (Jacobs, 2000). Trabecular bone with porosity ranging from 
Figure 2.2: Bone cells classified to three groups Osteoblast, Osteocyte, and 
Osteoclast (Zhang, 1999). 
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75% to 95% is usually found in cubicoidal and flat bones (e.g., vertebrae and pelvis) 
and in the end of long bones (e.g., femur). Trabecular bone accounts for 
approximately 80% of the skeletal volume and 70% of the skeletal mass is cortical 
bone. The microstructure of trabecular bone is composed of irregular, sinuous 
convolutions of lamellae, and the microstructure of cortical bone is comprised of 
regular, cylindrically shaped lamellae. Cortical bone is composed of osteons or 
Haversian canals. The osteons are embedded in a matrix of lamellar bone known as 
interstitial lamellae (Rho et al., 1998). 
 
Lamellae are bands or layers of bone (3 µm to 7 µm thick) forming an 
anisotropic matrix of mineral crystals and collagen fibers (Jacobs, 2000). Trabecular 
packets and osteons are composed of lamellae and are attached to the bone matrix by 
cement lines. At the molecular level (in the scale of ≤100 nm), three main important 
materials exist, namely, biologic apatite crystals, collagens, and noncollagenous 
organic proteins. Mature crystals are not needle shaped but plate shaped (Rho et al., 
1998; Weiner and Wagner, 1998). Plate-like biological apatite crystals of bone occur 
within the isolated spaces within the collagen fibrils. This phenomenon limits the 
possible primary growth of the mineral crystals and forces the crystals to be discrete 
and discontinuous (Rho et al., 1998; Weiner and Wagner, 1998). The nanocrystalline 
bone apatite has small but significant amounts of impurities, such as HPO4, Na, Mg, 
citrate, carbonate, and K. Similar to the crystal of HA, the crystal of carbonate apatite 
not only exhibits a hexagonal crystal structure but also produces X-ray diffraction 
patterns (Weiner and Wagner, 1998). Weiner et al. (1999) proposed that their plate-
like structure is attributed to their growth by an octacalcium phosphate transition 
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phase. Octacalcium phosphate crystals are plate shaped and have a similar structure 
to apatite, except for the presence of a hydrated layer. 
 
2.1.2 Mechanical Properties of Bone 
The mechanical properties of trabecular and cortical bones including 
compressive strength, tensile strength, Young’s modulus, hardness, and fracture 
toughness have been extensively studied. Differences between whole bones perhaps 
explained by the variation in the structure and mechanical function of bones (Rho et 
al., 1998). The mechanical properties of cortical bone (tibia, femur, and humerus) are 
significantly influenced by the porosity, mineralization level, and organization of the 
solid matrix. The mechanical properties of cortical bone vary between subjects, 
although the density remains the same. In contrast to cortical bone, in trabecular 
bone, the mechanical properties of the humerus, proximal tibia, and lumbar spine are 
not different (Rho et al., 1995; Zhou and Lee, 2011). 
 
The strength and mechanical properties of bone depend on bone density, 
porosity, and molecular structure. Other factors, such as, humidity, mode of applied 
load, direction of the applied load, and location of bone within the body, affect the 
mechanical properties of bone (Rho et al., 1998). 
 
2.1.3 Bone and implantation  
Bones are relatively rigid structures and their shapes are closely related to their 
functions. Bone metabolism is mainly controlled by the endocrine, immune, and 
neurovascular systems, and its metabolism and response to internal and external 
stimulations are still under assessment (Ratner et al., 2012). Disturbance to normal 
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function and metabolism of bone causes with any stimuli, ended in bone disease, and 
need of different treatment. Long bones are most part of skeletal system to injury, 
and internal or external fixation is a part of their treatment. Joint replacement is main 
intervention where the bone is expected to host biomaterials. Response of the bone to 
biomaterial arbitrates with the regeneration procedure. Materials implanted into the 
bone, nevertheless, cause local and systemic biological responses even if they are 
known to be inert (Ratner et al., 2012).  
 
Biomaterials are the natural or synthetic material that is used to replace or 
restore function of body tissue. Currently the wide ranges of materials used in 
medicine and biotechnology.  These materials are mainly divided into four classes; 
polymers, metals, ceramics, and natural materials (including those from both plants 
and animals). Different classed of this material can be mixed to develop composite 
material with increased biocompatibility, efficacy in treatment; end result will be 
calss fifth which call composite material.  Examples of the fifth class of biomaterial 
are silica-reinforced silicone rubber or carbon fiber- or hydroxyapatite particle-
reinforced (Ratner et al., 2012). 
 
The application of exogenous material in treatment was started back in 1960s, 
during World War II. Surgeons had used commercially available polymers and 
metals, fabricating implants and components of medical devices from them, as 
replacement for lost part in the body (Thomas, 2004). The first generations of use 
biomaterial in implantation happen to be impressively effective; however there were 
a few failure rejections due to infection. This achievement in medication made 
surgeons to consider the physical, biological, and materials science and engineering, 
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where by the earliest interdisciplinary “bioengineering” collaborations were born. 
These collaborative research teams not only focus to control the biomaterial 
composition, quality, and purity, they also established the need for new materials 
with new and special properties. This stimulated the development of many new 
materials in the 1970s (Thomas, 2004; Ratner et al., 2012).  
 
Biomaterials were specifically designed to be physically replaced the hard or 
soft tissues, which suffer from a variety of destructive processes including fracture, 
infection, and cancer that cause pain, disfigurement, or loss of function. Suture is one 
of the oldest and literary the first generation of biomaterial used in wound healing 
process. Back to 2000 b.c, the ancient Egyptians used linen to holding together the 
edges of a wound or surgical incision. Later by developed technology synthetic 
suture material like polymer (the most widely used) and some metal stainless steels 
and tantalum were replace with it. The used biomaterial not summarized to wound 
healing device also a wide range of biomaterials with multiplicity of properties are 
used to produce ocular devices to correct functional deficiencies caused by disease, 
age and ocular trauma (Lloyd et al., 2001).  
 
Metals, ceramics and polymers used to replace defected part in the 
cardiovascular, or circulatory system. The heart valves suffer from structural changes 
that prevent the valve from either fully opening or fully closing and arteries, 
particularly the coronary arteries and the vessels of the lower limbs, become blocked 
by fatty deposits (atherosclerosis), all these can be successfully treated with implants. 
Bacterial infections, dental caries (cavities), the demineralization and dissolution of 
teeth associated with the metabolic activity in plaque, cause extensive damage to the 
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tooth and supporting gum, raise the need of tissue replacement. The need of tissue 
replacement introduces another area for use of biomaterial. Therefore, verities of 
material use to replace segment or entire teeth in their entirety.  
 
One of the fastest growing areas for implant applications is devices for 
controlled and targeted delivery of drugs. This area of implantation focus on the 
synthesis, fabrication, and evaluation of biomaterials, including nanobiomaterials for 
important applications in biomedicine. Drug delivery implantation emphasize the 
development of novel biomaterials with exciting or improved physical, chemical, and 
biological properties to control drug delivery and selectivity, and increased the 
efficacy of drug.  
 
Orthopedics implant is the most dominant area for application biomaterials; 
free movable joint in skeleton like hip, knee, shoulder, ankle, and elbow, affected by 
chronic condition of osteoarthritis and rheumatoid arthritis. These chronic conditions 
developed by genetic and environmental factors, aging joints, previous injuries, and 
obesity affect the structure of synovial joints and induce considerable pain in joints 
especially weight bearing joint and disturb the joint movement . The interruption in 
ambulatory function quite devastating but it has been possible to replace these joints 
with orthopedic implants products. Wide range of metals, polymers, ceramics, and 
composites used within the manufacture of orthopedics implants the relief of pain 
and restoration of mobility. There are many deal to be made before the material can 
be produced and these summarized in Figure 2.3.  
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Manufacturing 
 Fabrication methods  
 Consistency and conformity 
to all requirements  
 Quality of raw materials  
 Superior techniques to obtain 
excellent surface finish or 
texture  
 Capability of material to get 
safe and efficient sterilization  
 Cost of product   
 
 
Requirements of implants 
Compatibility 
 Tissue reaction 
 Changes in properties 
a) Mechanical 
b) Physical 
c) Chemical 
 Degradation leads to 
d) Local deleterious 
changes 
a) Harmful systemic 
effects 
Mechanical properties 
 Elasticity  
 Yield stress 
 Ductility 
 Toughness 
 Time dependent 
deformation  
 Creep  
 Ultimate strength  
 Fatigue strength  
 Hardness  
 Wear resistance  
Figure 2.3: Implant material requirement in orthopedic application 
